View Item 

Show simple item record

Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study
dc.contributor.authorPappas, Peter G.en_US
dc.contributor.authorAndes, D.en_US
dc.contributor.authorSchuster, M.en_US
dc.contributor.authorHadley, S.en_US
dc.contributor.authorRabkin, John M.en_US
dc.contributor.authorMerion, Robert M.en_US
dc.contributor.authorKauffman, C. A.en_US
dc.contributor.authorHuckabee, C.en_US
dc.contributor.authorCloud, Gretchen A.en_US
dc.contributor.authorDismukes, William E.en_US
dc.contributor.authorKarchmer, A. W.en_US
dc.date.accessioned2010-06-01T21:01:10Z
dc.date.available2010-06-01T21:01:10Z
dc.date.issued2006-02en_US
dc.identifier.citationPappas, P. G.; Andes, D.; Schuster, M.; Hadley, S.; Rabkin, J.; Merion, R. M.; Kauffman, C. A.; Huckabee, C.; Cloud, G. A.; Dismukes, W. E.; Karchmer, A. W. (2006). "Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study." American Journal of Transplantation 6(2): 386-391. <http://hdl.handle.net/2027.42/74111>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74111
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16426325&dopt=citationen_US
dc.format.extent188171 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherMunksgaard International Publishersen_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 The American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherAntifungalen_US
dc.subject.otherFungal Infectionsen_US
dc.subject.otherInvasive Candidiasisen_US
dc.subject.otherLiver Transplant Recipientsen_US
dc.subject.otherProphylaxisen_US
dc.titleInvasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Studyen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationotherUniversity of Alabama at Birmingham Medical Centeren_US
dc.contributor.affiliationotherUniversity of Wisconsin Health Sciences Center, Madison, WIen_US
dc.contributor.affiliationotherUniversity of Pennsylvania Medical Center, Philadelphia, PAen_US
dc.contributor.affiliationotherNew England – Tufts Medical Center, Boston, MAen_US
dc.contributor.affiliationotherUniversity of Oregon Health Sciences Center, Portland, ORen_US
dc.contributor.affiliationotherRho Incorporated, Chapel Hill, NCen_US
dc.contributor.affiliationotherBeth Israel-Deaconess Medical Center, Boston, MAen_US
dc.identifier.pmid16426325en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74111/1/j.1600-6143.2005.01176.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2005.01176.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferencePaya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677 – 688.en_US
dc.identifier.citedreferenceCastaldo P, Stratta RJ, Wood P et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149 – 156.en_US
dc.identifier.citedreferenceWajszczuk CP, Dummer JS, Ho M et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347 – 353.en_US
dc.identifier.citedreferenceKusne S, Dummer JS, Singh N et al. Infections after liver transplantation. Medicine 1988; 67: 132 – 143.en_US
dc.identifier.citedreferenceHadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59: 851 – 859.en_US
dc.identifier.citedreferenceHusain S, Tollemar J, Dominguez EA et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023 – 2029.en_US
dc.identifier.citedreferenceSingh N, Gayowski T, Wagener MM, Doyle H, Marino IR. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997; 24: 179 – 184.en_US
dc.identifier.citedreferenceSingh N, Avery RK, Munoz P et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46 – 52.en_US
dc.identifier.citedreferencePatel R, Portela D, Badley A et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996; 62: 926 – 934.en_US
dc.identifier.citedreferenceViviani MA, Tortorano AM, Malaspina C et al. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. Eur J Epidemiol 1992; 8: 433 – 436.en_US
dc.identifier.citedreferenceWade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328 – 1336.en_US
dc.identifier.citedreferenceCollins LA, Samore MH, Roberts MS et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170: 644 – 652.en_US
dc.identifier.citedreferenceKarchmer AW, Samore MH, Hadley S, Collins LA, Jenkins L, Lewis WD. Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc 1995; 106: 38 – 48.en_US
dc.identifier.citedreferenceHadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Transplant 1995; 9: 1045 – 1074.en_US
dc.identifier.citedreferenceBriegel J, Forst H, Spill B et al. Risk factors for systemic fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 1995; 14: 375 – 382.en_US
dc.identifier.citedreferenceRabkin JM, Oroloff SL, Corless CL et al. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 2000; 179: 427 – 430.en_US
dc.identifier.citedreferenceBiancofiore G, Bindi ML, Baldassarri R et al. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl Int 2002; 15: 341 – 374.en_US
dc.identifier.citedreferenceBraun F, RÜchel R, Lorf R et al. Is liposomal amphotericin B (Ambisome) an effective prophylaxis of mycotic infections after liver transplantation? Transplant Proc 1998; 30: 1481 – 1483.en_US
dc.identifier.citedreferenceFisher NC, Singhal S, Miller SJ, Hastings JGM, Mutimer DJ. Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review. J Antimicrob Chemother 1999; 43: 597 – 600.en_US
dc.identifier.citedreferenceFortun J, Martin-Davila P, Moreno S et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin in high-risk patients. J Antimicrob Chemother 2003; 52: 813 – 819.en_US
dc.identifier.citedreferenceLumbreras C, Cuervas-Mons V, Jara P et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.. J Infect Dis 1996; 174: 583 – 588.en_US
dc.identifier.citedreferenceMora NP, Klintmalm G, Solomon G, Goldstein RM, Gonwa TA, Husberg BS. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc 1992; 24: 154 – 155.en_US
dc.identifier.citedreferenceSharpe MD, Ghent C, Grant C, Horbay GLA, McDougal J, Colby WD. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 2003; 76: 977 – 983.en_US
dc.identifier.citedreferenceSingh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910 – 913.en_US
dc.identifier.citedreferenceTollemar J, Hockerstedt K, Ericzon BG, Jalanko H, RingdÈn O. Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial. Transplant Proc 1995; 27: 1195 – 1198.en_US
dc.identifier.citedreferenceWinston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729 – 737.en_US
dc.identifier.citedreferenceWinston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002; 74: 688 – 695.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2005.01176.x.pdf
Size:
183.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.